Literature DB >> 34307762

Reply to Comment on: Successful Treatment of Levodopa/Carbidopa Intestinal Gel Associated "Biphasic-Like" Dyskinesia with Pallidal Deep Brain Stimulation.

Eoin Mulroy1, Valentina Leta2, Ludvic Zrinzo1, Thomas Foltynie1, Kallol Ray Chaudhuri2, Patricia Limousin1.   

Abstract

Entities:  

Keywords:  Parkinson's disease; deep brain stimulation; hyperkinesis

Year:  2021        PMID： 34307762      PMCID： PMC8287198          DOI： 10.1002/mdc3.13221

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  8 in total

1.  End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation.

Authors:  Diana Apetauerova; R Kevin Ryan; Susie I Ro; Jeffrey Arle; Jay Shils; Efstathios Papavassiliou; Daniel Tarsy
Journal:  Mov Disord       Date:  2006-08       Impact factor: 10.338

2.  "Silly walks" in Parkinson's disease: unusual presentation of dopaminergic-induced dyskinesias.

Authors:  Evžen Růžička; Kateřina Zárubová; John G Nutt; Bastiaan R Bloem
Journal:  Mov Disord       Date:  2011-04-14       Impact factor: 10.338

3.  From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.

Authors:  P Krack; P Pollak; P Limousin; A Benazzouz; G Deuschl; A L Benabid
Journal:  Brain       Date:  1999-06       Impact factor: 13.501

4.  Impact of the motor complications of Parkinson's disease on the quality of life.

Authors:  Stéphane Chapuis; Lemlih Ouchchane; Olivier Metz; Laurent Gerbaud; Franck Durif
Journal:  Mov Disord       Date:  2005-02       Impact factor: 10.338

5.  Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.

Authors:  C Warren Olanow; Karl Kieburtz; Per Odin; Alberto J Espay; David G Standaert; Hubert H Fernandez; Arvydas Vanagunas; Ahmed A Othman; Katherine L Widnell; Weining Z Robieson; Yili Pritchett; Krai Chatamra; Janet Benesh; Robert A Lenz; Angelo Antonini
Journal:  Lancet Neurol       Date:  2013-12-20       Impact factor: 44.182

6.  Apomorphine and diphasic dyskinesia.

Authors:  F Durif; D Deffond; G Dordain; M Tournilhac
Journal:  Clin Neuropharmacol       Date:  1994-02       Impact factor: 1.592

7.  Successful Treatment of Levodopa/Carbidopa Intestinal Gel Associated "Biphasic-like" Dyskinesia with Pallidal Deep Brain Stimulation.

Authors:  Eoin Mulroy; Valentina Leta; Ludvic Zrinzo; Thomas Foltynie; K Ray Chaudhuri; Patricia Limousin
Journal:  Mov Disord Clin Pract       Date:  2021-01-05

8.  Pallidal versus subthalamic nucleus deep brain stimulation for levodopa-induced dyskinesia.

Authors:  Shi-Ying Fan; Kai-Liang Wang; Wei Hu; Robert S Eisinger; Alexander Han; Chun-Lei Han; Qiao Wang; Shimabukuro Michitomo; Jian-Guo Zhang; Feng Wang; Adolfo Ramirez-Zamora; Fan-Gang Meng
Journal:  Ann Clin Transl Neurol       Date:  2019-12-08       Impact factor: 4.511
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.